{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:22:18Z","timestamp":1789917738140,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.annepidem.2009.03.018","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T05:59:16Z","timestamp":1244699956000},"page":"494-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Analysis of the Quality of Reporting of Randomized Controlled Trials in Acute and Chronic Myeloid Leukemia, and Myelodysplastic Syndromes as Governed by the CONSORT Statement"],"prefix":"10.1016","volume":"19","author":[{"given":"Dimitrios C.","family":"Ziogas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Zintzaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2009.03.018_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9343(98)00391-X","article-title":"The quality of medical evidence in hematology-oncology","volume":"106","author":"Djulbegovic","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.annepidem.2009.03.018_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S0266462300009570","article-title":"Assessing the quality of randomized controlled trials. Current issues and future directions","volume":"12","author":"Moher","year":"1996","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.annepidem.2009.03.018_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/bmj.313.7057.570","article-title":"Better reporting of randomised controlled trials: the CONSORT statement","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.annepidem.2009.03.018_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/djj160","article-title":"Reporting of Randomized Controlled Trials in Hodgkin Lymphoma in Biomedical Journals","volume":"98","author":"Kober","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annepidem.2009.03.018_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0360-3016(90)90156-E","article-title":"Influence of clinical trials on current treatment strategy for Hodgkin's disease","volume":"19","author":"Bonadonna","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.annepidem.2009.03.018_bib6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.1990.03440100140020","article-title":"The continued use of retracted invalid scientific literature","volume":"263","author":"Pfeifer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.03.018_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/sim.4780140507","article-title":"Meta-analysis: reconciling the results of independent studies","volume":"14","author":"Olkin","year":"1995","journal-title":"Stat Med"},{"key":"10.1016\/j.annepidem.2009.03.018_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2009.03.018_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.03.018_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.03.018_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.cct.2005.02.008","article-title":"The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement","volume":"26","author":"Mills","year":"2005","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.annepidem.2009.03.018_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.annepidem.2009.03.018_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jech.51.4.354","article-title":"Putting trials on trial\u2013the costs and consequences of small trials in depression: a systematic review of methodology","volume":"51","author":"Hotopf","year":"1997","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.annepidem.2009.03.018_bib14","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.1986.4.6.942","article-title":"A quality assessment of randomized control trials of primary treatment of breast cancer","volume":"4","author":"Liberati","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annepidem.2009.03.018_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ije\/dym087","article-title":"Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials","volume":"36","author":"Pildal","year":"2007","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.annepidem.2009.03.018_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-134-8-200104170-00011","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"134","author":"Moher","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annepidem.2009.03.018_bib17","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.03.018_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"The revised CONSORT statement for reporting randomized trials: explanation and elaboration","volume":"134","author":"Altman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annepidem.2009.03.018_bib19","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1001\/jama.285.15.2006","article-title":"CONSORT revised\u2013improving the reporting of randomized trials","volume":"285","author":"Rennie","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.03.018_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1741-7015-6-13","article-title":"Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research","volume":"6","author":"Moher","year":"2008","journal-title":"BMC Med"},{"key":"10.1016\/j.annepidem.2009.03.018_bib21","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1001\/jama.285.15.1992","article-title":"Use of the CONSORT Statement and quality of reports of randomized trials: a comparative before-and-after evaluation","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.03.018_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5694\/j.1326-5377.2006.tb00557.x","article-title":"Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review","volume":"185","author":"Plint","year":"2006","journal-title":"Med J Aust"},{"key":"10.1016\/j.annepidem.2009.03.018_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.1996.03540080071033","article-title":"How to report randomized controlled trials: the CONSORT statement","volume":"276","author":"Rennie","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.03.018_bib24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0140-6736(05)64795-2","article-title":"Lies, damn lies, and reports of RCTs","volume":"348","author":"McNamee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2009.03.018_bib25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/09286580701344399","article-title":"Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals","volume":"14","author":"Lai","year":"2007","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.annepidem.2009.03.018_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijsu.2007.06.002","article-title":"The reporting quality of randomised controlled trials in surgery: a systematic review","volume":"5","author":"Agha","year":"2007","journal-title":"Int J Surg"},{"key":"10.1016\/j.annepidem.2009.03.018_bib27","first-page":"2476","article-title":"Quality of reporting of randomized clinical trials in abstracts of the 2005 annual meeting of the American College of Rheumatology","volume":"34","author":"Hill","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annepidem.2009.03.018_bib28","first-page":"266","article-title":"A systematic review of the quality of publications reporting coronary artery bypass grafting trials","volume":"50","author":"Farrokhyar","year":"2007","journal-title":"Can J Surg"},{"key":"10.1016\/j.annepidem.2009.03.018_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.328.7430.22","article-title":"Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group","volume":"328","author":"Soares","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.annepidem.2009.03.018_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2125.2004.2092.x","article-title":"Determining the reporting quality of RCTs in clinical pharmacology","volume":"58","author":"Mills","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.annepidem.2009.03.018_bib31","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jama.295.10.1147","article-title":"Quality of reporting on noninferiority and equivalence randomized trials","volume":"295","author":"Le Henanff","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.03.018_bib32","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jama.295.10.1152","article-title":"CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement","volume":"295","author":"Piaggio","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.03.018_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/sim.4780080408","article-title":"How study design affects outcomes in comparisons of therapy","volume":"8","author":"Colditz","year":"1989","journal-title":"Stat Med"},{"key":"10.1016\/j.annepidem.2009.03.018_bib34","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1001\/jama.287.21.2801","article-title":"Quality of reporting of randomized trials as a measure of methodologic quality","volume":"287","author":"Huwiler-M\u00fcntener","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.03.018_bib35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0895-4356(02)00440-7","article-title":"Discrepancy between published reports and actual conduct of randomized clinical trials","volume":"55","author":"Hill","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.annepidem.2009.03.018_bib36","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/bmj.330.7499.1056","article-title":"Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors","volume":"330","author":"Altman","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.annepidem.2009.03.018_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(96)90538-3","article-title":"Completeness of reporting of trials published in languages other than English: implications for the conduct of systematic reviews","volume":"347","author":"Moher","year":"1996","journal-title":"Lancet"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279709001070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279709001070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:06:25Z","timestamp":1760925985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279709001070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1047279709001070"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2009.03.018","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the Quality of Reporting of Randomized Controlled Trials in Acute and Chronic Myeloid Leukemia, and Myelodysplastic Syndromes as Governed by the CONSORT Statement","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2009.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}